Overordnet set lignede sikkerhedsprofilen for patienter behandlet med VELCADE som monoterapi den profil, som blev observeret hos patienter behandlet med VELCADE i kombination med melphalan og prednison.
Overall, the safety profile of patients treated with VELCADE in monotherapy was similar to that observed in patients treated with VELCADE in combination with melphalan and prednisone.